Published Nov 30, 2015
Episode 4: Can a Hedge Funder Cut Prescription Drug Costs?
Explore the exploitative strategies of hedge fund manager Kyle Bass as he challenges pharmaceutical patents to potentially reduce prescription drug costs, sparking debate over the ethics and impact of these financial maneuvers.
Topics covered
Popular Clips
Episode Highlights
Related Episodes
How To Fund The Search For A COVID-19 Vaccine And Boost The Recovery
Answers 383 questions
John Hempton on Greensill, Archegos and What It's Like To Short Right Now
Answers 383 questions
Canada's Cannabis Market So Far
Answers 383 questions
How A New Type Of Money Helped Cause The Great Financial Crisis
Answers 383 questions
What the Market Crash Says About How Investing Works
Answers 383 questions
58: Ignore Investing's Mathematical Underpinnings at Your Peril
Answers 383 questions
Here's What Just Happened to the Stock Market and the Economy
Answers 383 questions
How the Rise of 'Pod Shops' Is Reshaping the Way Markets Trade
Answers 383 questions
A Forensic Accounting Expert Explains How Companies Trick Investors
Answers 383 questions
46: Space Robots Are Helping Hedge Funds Invest
Answers 383 questions
How Hedge Funds Discover the Next Superstar Trader
Answers 383 questions
ETFs Are Eating the Financial World and They're Not Done Yet
Answers 383 questions
How to Succeed at Multi-Strategy Hedge Funds
Answers 383 questions
Episode 7: How One Woman Tried To Sound Housing Crash Alarm
Answers 383 questions
Making Bitcoin A Currency People Use
Answers 383 questions